National Prescribing Trends of Direct-Acting Antivirals for Hepatitis C
JAMA · 05.05.2026 · 335 (17) · 1531
DOI: 10.1001/jama.2026.3328 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 05.05.2026. Verfasst von Sanjay Kishore und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Virginia School of Medicine, Charlottesville. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This study measures changes in patient and prescriber characteristics for direct-acting antivirals to treat hepatitis C virus infection from 2013 to 2025 in the US.
Autor:innen und Institutionen
- Department of Medicine, University of Virginia School of Medicine, Charlottesville.
- Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
- Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Zitieren
APA
Kishore, S., Hayden, M., Johnson, M., Kesselheim, A. S., & Rome, B. N. (2026). National Prescribing Trends of Direct-Acting Antivirals for Hepatitis C. JAMA, 335(17), 1531. https://doi.org/10.1001/jama.2026.3328
Vancouver
Kishore S, Hayden M, Johnson M, Kesselheim AS, Rome BN. National Prescribing Trends of Direct-Acting Antivirals for Hepatitis C. JAMA. 2026;335(17):1531. doi:10.1001/jama.2026.3328
BibTeX
@article{Kishore2026,
author = {Kishore, Sanjay and Hayden, Margaret and Johnson, Micah and Kesselheim, Aaron S and Rome, Benjamin N},
title = {National Prescribing Trends of Direct-Acting Antivirals for Hepatitis C},
journal = {JAMA},
year = {2026},
volume = {335},
number = {17},
pages = {1531},
doi = {10.1001/jama.2026.3328}
}
EUVIMED